Market cap
₹39 Cr
Revenue (TTM)
₹859 Cr
P/E Ratio
2.6
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹15 Cr
-
ROE
5.7 %
-
ROCE
4.2 %
-
Industry P/E
31.55
-
EV/EBITDA
10.1
-
Debt to Equity
1
-
Book Value
₹--
-
EPS
₹0.1
-
Face value
1
-
Shares outstanding
2,044,860,741
10 Years Aggregate
CFO
₹-354.30 Cr
EBITDA
₹6.18 Cr
Net Profit
₹16.51 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Murae Organisor
| -26.9 | -9.5 | -29.6 | -69.7 | -38.8 | -- | -- |
|
BSE Healthcare*
| 8.7 | 11.0 | 10.7 | 11.7 | 26.8 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Murae Organisor
| -73.4 | 68.9 | -53.6 | -71.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Murae Organisor
|
0.2 | 38.9 | 858.6 | 15.2 | 1.3 | 6.4 | 2.6 | 0.2 |
| 3,177.2 | 39,663.3 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37.6 | 8.8 | |
| 8,468.5 | 21,221.1 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.6 | 25.5 | |
| 1,998.8 | 15,193.6 | 2,187.2 | 649.7 | 31.5 | 19 | 23.7 | 4.2 | |
| 1,370.9 | 19,038.5 | 3,078.2 | 469.4 | 26.4 | 14.9 | 44.1 | 5.3 | |
| 2,140.4 | 34,313.8 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.4 | 8.3 | |
| 4,954.7 | 22,595.0 | 2,519.7 | 722.4 | 33.6 | 18.8 | 31.3 | 5.4 | |
| 5,300.0 | 8,775.4 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29.9 | 12.6 | |
| 478.4 | 9,358.6 | 1,432.0 | 149.0 | 19.1 | 7.9 | 62.4 | 3.8 | |
| 1,153.7 | 10,636.7 | 4,725.6 | 528.7 | 14.9 | 20.7 | 20.8 | 3.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Murae Organisor
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
2012
-
Chairman
--
-
Managing Director
Chinmay Pradhan
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Murae Organisor Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Murae Organisor
What is the current share price of Murae Organisor Ltd Today?
The share price of Murae Organisor Ltd is ₹0.19 (BSE) as of 25-Mar-2026 IST. Murae Organisor Ltd has given a return of -38.82% in the last 3 years.
What is the current PB & PE ratio of Murae Organisor Ltd?
The P/E ratio of Murae Organisor Ltd is 2.56 times as on 25-Mar-2026, a 92 discount to its peers’ median range of 31.55 times.
The P/B ratio of Murae Organisor Ltd is 0.17 times as on 25-Mar-2026, a 96 discount to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.75
|
0.62
|
|
2024
|
302.49
|
0.63
|
|
2023
|
5.55
|
0.70
|
|
2022
|
12.70
|
2.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Murae Organisor Ltd?
The 52-week high and low of Murae Organisor Ltd are Rs 1.12 and Rs 0.19 as of 17-May-2026.
What is the market cap of Murae Organisor Ltd?
Murae Organisor Ltd has a market capitalisation of ₹ 39 Cr as on 25-Mar-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Murae Organisor Ltd?
Before investing in Murae Organisor Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.